Description

Glimepirid-TEVA Tablets 4 mg. №30

Ingredients:

Each tablet contains 4 mg of Glimepiride.

Mechanism of Action:

Glimepiride, the active ingredient in Glimepirid-TEVA tablets, stimulates the release of insulin from pancreatic beta cells, effectively lowering blood sugar levels. This mechanism helps in controlling glucose levels in patients with type 2 diabetes mellitus.

Pharmacological Properties:

Glimepirid-TEVA tablets belong to the sulfonylurea class of drugs and act by increasing insulin release from the pancreas, thereby reducing blood sugar levels.

Indications for Use:

Glimepirid-TEVA tablets are indicated for the treatment of type 2 diabetes mellitus in adult patients.

Contraindications:

Avoid the use of Glimepirid-TEVA tablets in individuals with a known hypersensitivity to sulfonylureas.

Side Effects:

Common side effects of Glimepirid-TEVA tablets may include hypoglycemia, weight gain, and gastrointestinal disturbances. Rarely, severe allergic reactions may occur.

Usage Instructions:

Take Glimepirid-TEVA tablets as directed by your healthcare provider. The usual recommended dose is 4 mg once daily with a meal to ensure optimal absorption.

Benefits Compared to Analogues:

Compared to other sulfonylureas, Glimepirid-TEVA tablets offer a more convenient dosing regimen with once-daily administration and have shown comparable efficacy in managing blood sugar levels.

Suitable Patient Groups:

Glimepirid-TEVA tablets are suitable for adult patients with type 2 diabetes mellitus. Dosing adjustments may be necessary for elderly individuals or those with hepatic or renal impairment.

Storage Conditions and Shelf Life:

Store Glimepirid-TEVA tablets in a cool, dry place away from moisture and heat. Check the expiration date on the packaging and do not use the tablets if expired.

Packaging Description:

Glimepirid-TEVA tablets are available in a pack of 30 tablets, each containing 4 mg of Glimepiride. The packaging is designed to protect the tablets from environmental factors and maintain their stability.

Clinical Evidence and Proven Effectiveness:

Glimepirid-TEVA tablets have undergone rigorous clinical trials that have demonstrated their efficacy and safety in the management of type 2 diabetes. These studies have shown significant improvements in glycemic control and overall patient outcomes.